TCL Archive New: Special Reports on the Dialogue and NCI’s 2015 goal posted at cancerletter.com. August 8, 2003
TCL Archive Phase II Study Meets Primary Endpoint, Demonstrating Overall Survival of 5.2 Months September 27, 2013
TCL Archive Darbepoetin Didn’t Decrease Blood Transfusions, Lowered Overall Survival, Study Finds April 27, 2007